Logixx Pharma Limited

Logixx Pharma Ltd from Reading, UK, is a small holding company with an active status, established fifteen years ago in 2010. The company employs twelve people and holds assets totaling £2,681,324. Registered at a virtual address – twenty-six companies share this location – Logixx Pharma is managed by two directors and owned by a single individual. The firm regularly imports and exports optical and medical tools and devices, with nineteen months of import activity and thirty-five months of export activity recorded.

The company operates within the “other business support service activities n.e.c.” industries, suggesting a broad range of support services. While no website is available to examine, this could mean they act as a distributor or intermediary rather than a direct retailer.

Financially, Logixx Pharma shows a mixed picture. Net assets declined by 58%, dropping to £620,000, while current assets increased by 17% to £2.7 million. Bank borrowings decreased by 32%, reaching £220,000, and cash reserves fell dramatically by 85% to just £24,000. Creditors increased significantly by 150%, reaching £2.6 million, which could be a result of increased purchasing to meet export demands. Trade debtors increased by 17%, suggesting a longer payment cycle. The company meets the criteria for a small company – turnover under £10.2 million, assets under £5.1 million, and fewer than 50 employees. The lack of an auditor mentioned likely means the accounts are unaudited.

The sharp decline in equity, despite increased assets, is a point of concern. It’s possible that the company has invested heavily in inventory or equipment to support its import and export operations. The decrease in cash reserves, while worrying, could be a consequence of increased operational expenses and a reliance on credit.

Registered in England/Wales under the registration number 07209211, with a registered address at RG7 4AB, England, Reading, Berkshire, Merlin House Brunel Road, Theale.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.